The University of Chicago Header Logo

Connection

Walter M. Stadler to Immunoconjugates

Back to Details
This is a "connection" page, showing publications Walter M. Stadler has written about Immunoconjugates.
Walter M. Stadler
Connection Strength
0.122
Immunoconjugates
  1. First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70. Cancer Chemother Pharmacol. 2016 Jan; 77(1):155-62.
    View in: PubMed
    Score: 0.122
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.